4183 — Mitsui Chemicals Balance Sheet
0.000.00%
- ¥585bn
- ¥1tn
- ¥2tn
- 70
- 83
- 18
- 62
Annual balance sheet for Mitsui Chemicals, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 201,376 | 223,163 | 224,648 | 262,719 | 249,510 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 284,992 | 290,938 | 386,352 | 376,356 | 388,826 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 781,834 | 787,572 | 1,033,445 | 1,094,286 | 1,150,579 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 499,650 | 501,960 | 553,584 | 600,887 | 652,098 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,530,515 | 1,558,125 | 1,934,965 | 2,068,203 | 2,215,819 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 485,674 | 466,305 | 706,569 | 695,444 | 676,579 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,001,295 | 950,204 | 1,222,311 | 1,281,376 | 1,352,968 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 529,220 | 607,921 | 712,654 | 786,827 | 862,851 |
Total Liabilities & Shareholders' Equity | 1,530,515 | 1,558,125 | 1,934,965 | 2,068,203 | 2,215,819 |
Total Common Shares Outstanding |